Patient Leaflet Updated 12-Aug-2022 | Dr. Reddy's Laboratories (UK) Ltd
Zonisamide Dr. Reddy's 25mg, 50mg & 100mg Hard Capsules
Zonisamide Dr. Reddy’s 25 mg Hard Capsules
Zonisamide Dr. Reddy’s 50 mg Hard Capsules
Zonisamide Dr. Reddy’s 100 mg Hard Capsules
Zonisamide
1. What Zonisamide is and what it is used for
2. What you need to know before you take Zonisamide
3. How to take Zonisamide
4. Possible side effects
5. How to store Zonisamide
6. Contents of the pack and other information
The full name of this medicine is Zonisamide Dr. Reddy's 25 mg, 50 mg and 100 mg Hard Capsules but will be referred to as Zonisamide throughout this leaflet.
Zonisamide capsules contain the active substance zonisamide, and are used as an antiepileptic medicine.
Zonisamide is used to treat seizures that affect one part of the brain (partial seizure), which may or may not be followed by a seizure affecting all of the brain (secondary generalisation).
Zonisamide may be used:
Zonisamide belongs to a group of medicines (sulphonamides) which can cause severe allergic reactions, severe skin rashes, and blood disorders, which very rarely can be fatal (see section 4. Possible side effects)
Serious rashes occur in association with Zonisamide therapy, including cases of Stevens-Johnson syndrome.
Talk to your doctor or pharmacist before taking Zonisamide if you
The use of Zonisamide may lead to high levels of ammonia in the blood which could lead to a change in brain function, especially if you are also taking other medicines which can increase ammonia levels (for example valproate), have a genetic disorder causing build-up of too much ammonia in the body (urea cycle disorder), or if you have liver problems.
Tell your doctor immediately if you become unusually drowsy or confused.
If any of these applies to you, tell your doctor before you take Zonisamide.
Talk to your doctor about the following risks:
Preventing overheating and dehydration in children
Zonisamide can cause your child to sweat less and overheat and if your child is not treated this can lead to brain damage and death.
Children are most at risk especially in hot weather.
When your child is taking Zonisamide:
If your child’s skin feels very hot with little or no sweating, becomes confused, has muscle cramps, or your child’s heartbeat or breathing becomes rapid:
Do not give this medicine to children below the age of 6 years because it is not known for this age group whether the potential benefits are greater than the risks.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Zonisamide can be taken with or without food.
If you are a woman of childbearing age you must use adequate contraception while taking and for one month after stopping zonisamide.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. You should not stop your treatment without discussing this with your doctor.
Pregnancy
You must only take zonisamide during your pregnancy if your doctor tells you to. Research has shown an increased risk of birth defects in children of women taking anti-epileptic medicines.
A study showed that babies born to mothers using zonisamide during pregnancy were smaller than expected for their age at birth, compared with babies born to mothers treated with lamotrigine monotherapy.
Make sure you are fully informed about the risks and the benefits of using zonisamide for epilepsy during pregnancy.
Breastfeeding
Do not breastfeed whilst taking, or for one month after stopping Zonisamide.
Fertility
There are no clinical data available on the effects of zonisamide on human fertility. Studies in animals have shown changes in fertility parameters.
Zonisamide may affect your concentration, ability to react/respond, and may make you feel sleepy, particularly at the beginning of your treatment or after your dose is increased. Be especially careful while driving or operating machinery, if Zonisamide affects you in this way.
This medicine contains less than 1 mmol sodium (23 mg) per hard capsule, that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
When you take Zonisamide on its own:
When you take Zonisamide with other antiepileptic medicines:
Use in children (aged 6 to 11 years) and adolescents (aged 12 to 17 years) weighing at least 20 kg:
Example: A child who weighs 25 kg should take 25 mg once a day for the first week, and then increase the daily dose by 25 mg at the start of each week until a daily dose between 150 to 200 mg is reached.
If you feel that the effect of Zonisamide is too strong or too weak, talk to your doctor or pharmacist.
If you may have taken more Zonisamide than you should, tell a carer (relative or friend), your doctor or pharmacist immediately, or contact your nearest hospital casualty department, taking your medicine with you. You may become sleepy and could lose consciousness. You might also feel sick, have a sore stomach, muscle twitches, eye movement, feel faint, have a slowed heart beat, and reduced breathing and kidney function.
Do not try to drive.
If you forget to take a dose, don’t worry: take the next dose when it is due.
Do not take a double dose to make up for the forgotten dose.
Zonisamide is meant to be taken as a long-term medicine. Do not reduce your dose or stop your medicine unless your doctor tells you to.
If your doctor advises you to stop taking Zonisamide your dose will be reduced gradually to lower the risk of more seizures.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Zonisamide belongs to a group of medicines (sulphonamides) that can cause severe allergic reactions, severe skin rashes, and blood disorders, which very rarely can be fatal.
Your doctor may decide that you should stop using Zonisamide.
The most common side effects of Zonisamide are mild. They occur during the first month of treatment and usually decrease with continued treatment. In children ages 6 - 17 years old, side effects were consistent with those described below with the following exceptions: pneumonia, dehydration, sweating decreased (common) and abnormal liver enzymes (uncommon).
Very common side effects (may affect more than 1 in 10 people)
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Very rare side effects (may affect up to 1 in 10,000 people)
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, website www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Zonisamide 25 mg Hard Capsules
White to off-white granular powder in hard capsules, size 4 (14.3 mm x 5.31 mm), with a white to off white capsule body and a white to off-white capsule cap. The cap is imprinted with “A730” in black ink.
Zonisamide 50 mg Hard Capsules
White to off-white granular powder in hard capsules, size 3 (15.9 mm x 5.82 mm), with a white to off-white capsule body and a grey capsule cap.
The cap is imprinted with “A735” in black ink.
Zonisamide 100 mg Hard Capsules
White to off-white granular powder in hard capsules, size 1 (19.4 mm x 6.91 mm), with a white to off-white capsule body and a white to off-white capsule cap. The cap is imprinted with “A740” in black ink.
Zonisamide capsules are packaged in blisters supplied in boxes containing:
Not all pack sizes may be available.
Manufacturer
This leaflet was last revised in 06/2022
Dr. Reddy's Laboratories (UK) Limited, 410 Cambridge Science Park, Milton Road, Cambridge, CB4 0PE, UK
+44 (0)1748 828 873
+44 (0)1223 651 475
+44 (0)1223 728 010
http://www.drreddys.com/united-kingdom